AHR and experimental autoimmune encephalomyelitis: For example, AHR activation by its high-affinity ligand TCDD in vivo suppresses the development of experimental autoimmune encephalomyelitis (EAE), experimental autoimmune uveoretinitis, and spontaneous autoimmune diabetes (15, 28, 29).